Report authors : George Greenberg, Nancy DeLew Office of the Assistant Secretary for Planning and Evaluation (ASPE) U.S. Department of Health and Human Services
Prescription Drugs & Other Medical Products
Drugs and other medical products greatly impact human health and the health care system. ASPE conducts a variety of research in this area, including work related to medical product development and regulation; medical product markets, pricing and competition; prescription drug benefits and spending on medical products; medical product supply chains; and medical product safety.
Noteworthy
Reports
Displaying 141 - 150 of 177. 10 per page. Page 15.
Advanced SearchCost Effectiveness Considerations in the Approval and Adoption of New Health Technologies
Contents Background and Purpose Methodology Summary of Key Findings and Stakeholder Suggestions Conclusions and Policy Implications A.
Continuation of Drug Risk Adjustment
Prepared by: National Opinion Research Center (NORC) at the University of Chicago Prepared for:U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation
Compendium of Home Modification and Assistive Technology Policy and Practice Across States: Final Report
U.S. Department of Health and Human Services
National Estimates of Prescription Drug Utilization and Expenditures in Long-Term Care Facilities
This Policy Brief offers an updated look at prescription drug utilization by Medicare beneficiaries residing in long-term care facilities and reports, for the first time, national estimates of prescription drug spending by this population. [23 PDF pages]
Evaluation of New Measures of Assistive Technology and the Home Environment from the 2005 Pilot Study of Technology and Aging
U.S. Department of Health and Human Services
Analysis of the Characteristics of Medicare Advantage Plan Participation: Final Report
Contents
Project Purpose
Methods
Findings Descriptive Analysis of Trends
Findings Insight from Firm Discussions
Benefits, Marketing, and Product Positioning
Conclusions
Understanding Variations in International Drug Prices
Rapidly rising prescription drug prices have caused many consumers, third-party payers, and policymakers to look for ways to lower their drug costs. One strategy that many have seen as a potential solution is to import drug products from countries where drug prices are lower than those in the United States commonly called reimportation.
Development of an Assistive Technology and Environmental Assessment Instrument for National Surveys: Final Report
U.S. Department of Health and Human Services Development of an Assistive Technology and Environmental Assessment Instrument for National Surveys: Final Report Part I. Recommended Modules and Instrument Development Process